Genes that mediate breast cancer metastasis to lung

Article metrics

Abstract

By means of in vivo selection, transcriptomic analysis, functional verification and clinical validation, here we identify a set of genes that marks and mediates breast cancer metastasis to the lungs. Some of these genes serve dual functions, providing growth advantages both in the primary tumour and in the lung microenvironment. Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Selection of breast cancer cells metastatic to lung.
Figure 2: Gene-expression signature associated with lung metastasis.
Figure 3: Genes in the expression signature mediate lung metastasis.
Figure 4: Lung metastasis signature in human primary breast tumours.
Figure 5: Breast tumorigenicity and lung metastagenicity partially overlap.

References

  1. 1

    Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563–572 (2002)

  2. 2

    Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Rev. Cancer 3, 453–458 (2003)

  3. 3

    Yokota, J. Tumor progression and metastasis. Carcinogenesis 21, 497–503 (2000)

  4. 4

    Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–549 (2003)

  5. 5

    Clark, E. A., Golub, T. R., Lander, E. S. & Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000)

  6. 6

    Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117, 927–939 (2004)

  7. 7

    Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002)

  8. 8

    van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002)

  9. 9

    van 't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002)

  10. 10

    Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003)

  11. 11

    Solomayer, E. F., Diel, I. J., Meyberg, G. C., Gollan, C. & Bastert, G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res. Treat. 59, 271–278 (2000)

  12. 12

    Cailleau, R., Olive, M. & Cruciger, Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911–915 (1978)

  13. 13

    Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44–55 (2005)

  14. 14

    Shelly, M. et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 273, 10496–10505 (1998)

  15. 15

    Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127–137 (2001)

  16. 16

    Balkwill, F. Cancer and the chemokine network. Nature Rev. Cancer 4, 540–550 (2004)

  17. 17

    Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2, 161–174 (2002)

  18. 18

    Duffy, M. J., Maguire, T. M., Hill, A., McDermott, E. & O'Higgins, N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2, 252–257 (2000)

  19. 19

    Framson, P. E. & Sage, E. H. SPARC and tumour growth: where the seed meets the soil? J. Cell. Biochem. 92, 679–690 (2004)

  20. 20

    Wood, N. et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197, 703–709 (2003)

  21. 21

    Amatschek, S. et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumour-specific genes. Cancer Res. 64, 844–856 (2004)

  22. 22

    O'Hanlon, D. M. et al. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur. J. Cancer 38, 2252–2257 (2002)

  23. 23

    Desprez, P. Y., Sumida, T. & Coppe, J. P. Helix–loop–helix proteins in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 225–239 (2003)

  24. 24

    Ruzinova, M. B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13, 410–418 (2003)

  25. 25

    Arun, B. & Goss, P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin. Oncol. 31, 22–29 (2004)

  26. 26

    Beer, D. G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Med. 8, 816–824 (2002)

  27. 27

    Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000)

  28. 28

    Simon, R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br. J. Cancer 89, 1599–1604 (2003)

  29. 29

    Hynes, R. O. Metastatic potential: generic predisposition of the primary tumour or rare, metastatic variants-or both? Cell 113, 821–823 (2003)

  30. 30

    Heimann, R. & Hellman, S. Clinical progression of breast cancer malignant behaviour: what to expect and when to expect it. J. Clin. Oncol. 18, 591–599 (2000)

  31. 31

    Schairer, C., Mink, P. J., Carroll, L. & Devesa, S. S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J. Natl. Cancer Inst. 96, 1311–1321 (2004)

  32. 32

    Davidson, B. et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumour progression. Clin. Cancer Res. 10, 7335–7346 (2004)

  33. 33

    Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740–751 (2004)

Download references

Acknowledgements

We thank R. Benezra, Y. Kang, C. Hudis, L. Norton, N. Rosen and C. VanPoznak for insights and discussions, and K. Manova and the staff of the Molecular Cytology Core Facility for assistance with immunohistochemistry. A.J.M is a recipient of the Leonard B. Holman Research Pathway fellowship. G.P.G. is supported by an NIH Medical Scientist Training Program grant, a fellowship from the Katherine Beineke Foundation and a Department of Defense Breast Cancer Research Program pre-doctoral traineeship award. J.M. is an Investigator of the Howard Hughes Medical Institute. This research is supported by the W.M. Keck Foundation and an NIH grant to J.M., and a US Army Medical Research grant to W.G.

Author information

Correspondence to Joan Massagué.

Ethics declarations

Competing interests

All microarray data have been submitted to the Gene Expression Omnibus (GEO) under accession number GSE2603. Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Supplementary information

Supplementary Figure S1

This figure shows validation of a Rosetta-type poor prognosis gene-expression signature and its uniform expression among MDA-MB-231 cell lines. It also demonstrates that the SCPs fall into distinct groups based on gene expression patterns, and exhibit distinct metastatic tropisms. (PDF 214 kb)

Supplementary Figure S2

Confirmation of protein expression for lung metastasis signature genes used in functional validation. (PDF 107 kb)

Supplementary Figure S3

Validation of combination transgenic parental MDA-MB-231 cell lines transduced with lung metastasis genes. (PDF 114 kb)

Supplementary Figure S4

This figure demonstrates that parental MDA-MB-231 cells overexpressing lung metastasis genes are not enhanced in bone metastatic activity. (PDF 441 kb)

Supplementary Figure S5

In this figure, linear combinations of each of the 54 lung metastasis genes weighted by either its estimated Cox model regression coefficient or a t-statistic derived from comparing its expression between LM2 cell lines with the parental MDA-MB-231 cell lines are used to distinguish patients at high risk of developing lung but not bone metastasis. (PDF 129 kb)

Supplementary Figure S6

This figure identifies a subgroup of primary breast cancers that express the lung metastasis signature in the Rosetta data set using hierarchical clustering. (PDF 2056 kb)

Supplementary Figure S7

This figure demonstrates K-means clustering and comparison to LM2 gene expression centroids for primary breast cancers in the Rosetta data set. These methods are used to identify tumours that express the lung metastasis signature, which is used in class prediction training. (PDF 415 kb)

Supplementary Figure Legends

Descriptions of data presented in Supplementary Figures S1-S7. (DOC 32 kb)

Supplementary Tables

All supplementary tables referenced to in the text are included in this file. They include information on cell lines used in the study, as well as several gene lists that are derived in the course of the work. (DOC 216 kb)

Supplementary Data S1

This file contains a pivot table for the Affymetrix U133A gene expression data for all cell lines used in the study. (XLS 14613 kb)

Supplementary Data S2

This file contains an Affymetrix U133A pivot table for gene expression analysis of primary breast cancers in the MSKCC cohort. (XLS 14369 kb)

Supplementary Data S3

This file contains clinical annotations, gene lists, and results of class assignments and predictions utilized in Figure 4 of the main paper. (XLS 293 kb)

Supplementary Methods S1

Description of additional experimental procedures that was not included in the main text due to constraints on space. (DOC 34 kb)

Supplementary Methods S2

Detailed description of analytical methods used in the paper, including derivation of gene lists and class prediction algorithms. (DOC 102 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Minn, A., Gupta, G., Siegel, P. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005) doi:10.1038/nature03799

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.